Medicaid Lien Reduction Now Starts at Case Development, Not Settlement

For most of the last two decades, plaintiff firms treated Medicaid liens as a post-settlement problem. The case got worked up, the demand came in, somebody pushed back on the number, and the lien got resolved. That sequence still works in simple cases. In complex cases, it stopped working in 2022.

The Supreme Court’s decision in Gallardo v. Marstiller, 596 U.S. 420 (2022), did not change the federal anti-lien provision. It did not eliminate the pro-rata reduction. What it did was move the leverage point. After Gallardo, the size of a Medicaid lien reduction is decided long before the lien negotiation starts. It is decided during case development, by the valuation evidence the firm builds and the allocation strategy it commits to. Firms that still treat Medicaid as a back-end issue are leaving real money on the table.

Here is why the shift happened.

The reduction framework starts with Ahlborn

The reason any of this matters is that Medicaid liens have never been collectible at face value when the client settles below full case value. The Supreme Court settled that in Arkansas Department of Health and Human Services v. Ahlborn, 547 U.S. 268 (2006).

Ahlborn held that the federal anti-lien provision at 42 U.S.C. § 1396p(a)(1) bars state recovery from any portion of a settlement that does not represent payment for medical care. Pain and suffering, lost wages, loss of consortium, and every other non-medical category of damages sit outside the state’s reach. The only piece the state can touch is the medical share.

That holding produced what plaintiff firms now call the pro-rata method. Calculate what percentage the settlement represents of the case’s full value, then apply that same percentage to the amount Medicaid paid. The result is the reduced lien. A case worth $1 million that settles for $250,000 has captured 25 percent of full value, so a $100,000 Medicaid claim falls to $25,000.

Ahlborn is the foundation. Without it, there is no reduction argument at all. Wos v. E.M.A., 568 U.S. 627 (2013), then closed off a workaround states had tried, holding that a state cannot fix the medical share of a recovery by statutory presumption. The allocation has to be tied to the facts of the case.

That was the framework plaintiff firms operated under for sixteen years. Gallardo changed how the framework gets applied in the cases that matter most.

What Gallardo actually moved

Before Gallardo, plaintiff firms had a workable argument that state Medicaid recovery was limited to past medical expenses. The future medical figure sat outside the state’s reach. That made the reduction math fairly clean. Past medicals were the pool, the pro-rata percentage was applied, and the number was the number.

Gallardo held that states may recover from the portion of a settlement representing payment for medical care, past and future, when the state statute reaches future medicals. In states with statutes that reach future medicals, the pool the pro-rata percentage applies to expanded dramatically.

That single change reorganized the entire problem.

The math now turns on what fraction of the total recovery represents medical care of any kind. The medical share gets determined by how the case was valued and how the allocation between economic and non-economic damages was supported by the evidence. The lien negotiation cannot fix a weak valuation record. By the time the negotiation starts, the record is already set.

Why the timing of the work changed

Valuation is now where the reduction is won or lost. The evidence required to support a defensible valuation in the post-Gallardo environment is substantially more involved than what plaintiff firms historically built for Medicaid purposes alone. The pieces have to connect in ways that anticipate state agency scrutiny, and the work has to be done at a point in the case when most firms are not thinking about lien resolution at all.

The implication is that Medicaid eligibility should trigger a different posture throughout the case, from intake through settlement structure. The decisions that matter most for the lien reduction are not the ones that show up in the lien negotiation. They are the ones that happen months earlier, often before the firm has even thought about the lien. By the time the demand letter arrives, the record is either there or it is not.

The firms that do this well treat Medicaid lien reduction as a parallel workstream that runs alongside the underlying case, not as a task that begins when the case ends. That is a meaningful operational shift, and it is not one most plaintiff firms are set up to handle internally.

The bottom line

The framework that protects injured clients from paying full Medicaid demands has been in place for nearly two decades. What changed in 2022 is when the work to support that protection actually has to happen. Plaintiff firms that recognize the shift will keep producing strong reductions for their catastrophically injured clients. Plaintiff firms that do not will keep losing reductions they should have been able to win.

Most plaintiff firms do not have the bandwidth or the in-house expertise to build a Medicaid lien reduction the right way under Gallardo. The work overlaps with case strategy in ways that require both lien resolution experience and a working understanding of how the underlying case is being developed. That is the work I do, in partnership with the firms litigating these cases.

If you have a Medicaid eligible client and want help positioning the case to protect the strongest possible reduction, I handle Medicaid lien resolution nationwide. Contact me at office@merschbrocklaw.com.